North America Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line), Product (Equipment, and Media & Reagent), Application (Drug Discovery, Bioproduction, and Tissue Engineering), and Country
Market Introduction
The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.
Get more information on this report :
Market Overview and Dynamics
The North America cell line development market is expected to reach US$ 3,849.54million in 2027 from US$ 1,401.23million in 2019. The market is estimated to grow with a CAGR of 13.6% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the high rise in the number of cancer cases across North America and the increasing development in the biotechnology sector. However, the market growth is likely to be hindered owing to the cell line contamination by various microorganisms.
Key Market Segments
Based on type, the cell line development market is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell line. Based on product, the cell line development market is segmented into equipment, and media & reagent. Based on application, the cell line development market, is segmented into drug discovery, bioproduction, and tissue engineering.
Major Sources and Companies Listed
Some of the major primary and secondary sources for cell line development market included in the report are California Institute for Regenerative Medicine (CIRM), the American Society of Clinical Oncology, A Cancer Journal for Clinicians, and others.
Reasons to buy the report
- To understand the North America cell line development market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for cell line development market
- Efficiently plan M&A and partnership deals in North America cell line development market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form cell line development market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region
NORTH AMERICA CELL LINE DEVELOPMENT MARKET SEGMENTATION
By Type
- Primary Cell Line
- Hybridomas
- Continuous Cell Lines
- Recombinant Cell Line
- Equipment
- Media & Reagent
By Country
- North America
- US
- Canada
- Mexico
Company Profiles
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- SELEXIS
- BioFactura, Inc.
- WuXi AppTec
- LakePharma, Inc.
- General Electric
- Lonza
- Corning Incorporated
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Cell line development Market – By Type
1.3.2 Cell line development Market – By Product
1.3.3 Cell line development Market – By Application
1.3.4 North America Cell line development Market – By Country
2. North America Cell Line Development Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Cell Line Development Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Line Development Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Cell Line Development Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Rise in the Number of Cancer Cases across North America
5.1.2 Increasing Development in the Biotechnology Sector
5.2 Market Restraints
5.2.1 Cell Line Contaminationby Various Microorganisms
5.3 Market Opportunity
5.3.1 Increasing Investments by Government in Cell Line Development
5.4 Future Trend
5.4.1 Rising Company Participation with Innovative Strategies and Product Launches for Growth of Cell Line Development Market
5.5 Impact Analysis
6. Cell Line Development Market – North America Analysis
6.1 North America Cell Line Development Market Revenue Forecasts and Analysis
7. North America Cell Line Development Market Analysis and Forecasts To 2027 – ByType
7.1 Overview
7.2 Cell Line Development Market, by Type, 2019& 2027 (% Share)
7.3 Primary Cell Line
7.3.1 Overview
7.3.2 Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Hybridomas
7.4.1 Overview
7.4.2 Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Continuous Cell Lines
7.5.1 Overview
7.5.2 Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Recombinant Cell Line
7.6.1 Overview
7.6.2 Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Cell Line Development Market Analysis and Forecasts To 2027 – ByProduct
8.1 Overview
8.2 Cell Line Development Market, by Product, 2019& 2027 (% Share)
8.3 Equipment
8.3.1 Overview
8.3.2 Equipment Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Media and Reagent
8.4.1 Overview
8.4.2 Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
9. North America Cell Line Development Market Analysis – ByApplication
9.1 Overview
9.2 Cell Line Development Market Share by Application 2019& 2027 (%)
9.3 Drug Discovery
9.3.1 Overview
9.3.2 Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Bioproduction
9.4.1 Overview
9.4.2 Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Tissue Engineering
9.5.1 Overview
9.5.2 Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
10. Cell Line Development Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Cell Line Development Market, Revenue and Forecast to2027
10.1.1 Overview
10.1.2 North America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.3 North America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.4 North America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.5 North America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.6 North America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.1.7 US
10.1.7.1 US Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2 US Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.7.3 US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.7.4 US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.8 Canada
10.1.8.1 Canada Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.8.3 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.8.4 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.9 Mexico
10.1.9.1 Mexico Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.9.3 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.9.4 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11. Impact of COVID-19 Pandemic on North America Cell Line Development Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. COMPANY PROFILES
12.1 Merck KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Information
12.2.4 Product /Services Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 SELEXIS
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product/Service Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BioFactura, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 WuXi AppTec
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Service Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 LakePharma, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 General Electric
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Lonza
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Corning Incorporated
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of terms
LIST OF TABLES
Table 1. North America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. North America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 3. North America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 4. US Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 5. US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 6. US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 7. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 8. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 9. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 10. Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 11. Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 12. Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 13. Glossary of Terms, Cell Line Development Market
LIST OF FIGURES
Figure 1. Cell Line Development Market Segmentation
Figure 2. North America Cell Line Development Market Overview
Figure 3. Recombinant Cell Line Segment Held Largest Share of Typein Cell Line Development Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Cell Line Development Market - North America PEST Analysis
Figure 6. Cell Line Development Market Impact Analysis of Driver and Restraints
Figure 7. North America Cell Line Development Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 8. Cell Line Development Market, Type, 2019& 2027 (% Share)
Figure 9. Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 10. Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
Figure 11. Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
Figure 12. Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13. Cell Line Development Market, By Product, 2019& 2027 (% Share)
Figure 14. Equipment Market Revenue and Forecast to 2027 (US$ Mn)
Figure 15. Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
Figure 16. Cell Line Development Market Share by Application 2019& 2027 (%)
Figure 17. Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
Figure 18. Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
Figure 19. Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20. North America Cell Line Development Market Overview, By Country — 2019 (US$ Mn)
Figure 21. North America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 22. North America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
Figure 23. US Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 24. Canada Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 25. Mexico Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 26. Impact of COVID-19 Pandemic in North America Country Markets
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- SELEXIS
- BioFactura, Inc.
- WuXi AppTec
- LakePharma, Inc.
- General Electric
- Lonza
- Corning Incorporated
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America cell line development market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America cell line development market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.